These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 30697962

  • 21. Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway.
    Lee JH, Mohan CD, Shanmugam MK, Rangappa S, Sethi G, Siveen KS, Chinnathambi A, Alahmadi TA, Alharbi SA, Basappa S, Rangappa KS, Ahn KS.
    Biochimie; 2020 Aug; 175():58-68. PubMed ID: 32445654
    [Abstract] [Full Text] [Related]

  • 22. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
    Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J.
    Mol Cancer; 2011 Dec 15; 10():150. PubMed ID: 22171994
    [Abstract] [Full Text] [Related]

  • 23. STAT3 regulates the migration and invasion of a stem‑like subpopulation through microRNA‑21 and multiple targets in hepatocellular carcinoma.
    Zhang N, Duan WD, Leng JJ, Zhou L, Wang X, Xu YZ, Wang XD, Zhang AQ, Dong JH.
    Oncol Rep; 2015 Mar 15; 33(3):1493-8. PubMed ID: 25571964
    [Abstract] [Full Text] [Related]

  • 24. Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition.
    Zhou J, Hou J, Wang J, Wang J, Gao J, Bai Y.
    Life Sci; 2021 Nov 01; 284():119907. PubMed ID: 34453950
    [Abstract] [Full Text] [Related]

  • 25. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
    Cui L, Gao B, Cao Z, Chen X, Zhang S, Zhang W.
    Mol Med Rep; 2016 Mar 01; 13(3):2032-8. PubMed ID: 26781180
    [Abstract] [Full Text] [Related]

  • 26. [Interferon-β combined with all-trans retinoic acid supresses proliferation and promote apoptosis by inhibiting JAK2/STAT3 pathway in HepG2 human hepatocellular carcinoma cells].
    Zhao J, Nie W, Li W, Zhou X, Sun H, Zhu J, Chen J, Peng J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul 01; 32(7):901-5. PubMed ID: 27363269
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Amentoflavone reverses epithelial-mesenchymal transition in hepatocellular carcinoma cells by targeting p53 signalling pathway axis.
    Jian HY, Zhang JT, Liu Z, Zhang Z, Zeng PH.
    J Cell Mol Med; 2024 Jun 01; 28(11):e18442. PubMed ID: 38842135
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 01; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
    Fu LX, Lian QW, Pan JD, Xu ZL, Zhou TM, Ye B.
    J Biol Regul Homeost Agents; 2017 Jul 01; 31(1):51-58. PubMed ID: 28337870
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C, Guo F, Xu G, Ma J, Shao F.
    Oncol Rep; 2015 Apr 01; 33(4):1872-82. PubMed ID: 25653024
    [Abstract] [Full Text] [Related]

  • 40. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K/Akt/mTOR signaling pathway.
    Li CY, Wang Q, Wang X, Li G, Shen S, Wei X.
    Eur J Pharmacol; 2019 Sep 05; 858():172463. PubMed ID: 31211986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.